Three Medtech Startups Find Pulse of Innovation at UCI Beall Applied Innovation

Listicle
July 9, 2019 By Grace Wood

UC Irvine’s placement in Orange County, a medical device hub, and its status as one of the top 10 California schools for biomedical engineering, make it a cutting-edge epicenter for medical technology development. Unsurprisingly, there are many medtech startups in the UCI Beall Applied Innovation Wayfinder program and they cover a wide range of medical conditions, from skin problems to respiratory disease. Highlighted below are a few of these budding startups that hope to provide efficacy and efficiency for both clinicians and patients.

1. ELF Therapeutics
ELF Therapeutics – whose name stands for “Electrochemical Lysis of Fat” – won the 2019 Tech Surge track of the UCI New Venture Competition for its minimally invasive fat reduction technology based on electrochemistry. ELF is a needle-based procedure that can selectively break down fat cells in target fat tissues through electrochemically induced pH change. ELF can be used for contouring of double chin, belly bulge, love handles and spatially complex structures, such as abdominal six packs.

2. CBio
CBio’s technology, cellPhoresis, separates cells through electricity to quickly find differences in physical characteristics, structure, metabolism and more. Medical researchers have used separation technology to study pathogens such as E. coli and Sindbis virus, a mosquito-borne virus that results in fever and rash. These differences can also identify cell quality for bioremediation. Bioremediation uses microorganisms to eat waste products and convert them to ecologically friendly material. With this quality control, cellPhoresis can make the process more predictable and effective and have a positive environmental impact.

3. EndOptica
EndOptica develops minimally invasive solutions to cancer screening diagnostics, specifically in head, neck and pulmonary cancers. Their base technology, Optical Coherence Tomography, uses volumetric imaging, which produces 3D images that allow physicians to see the entirety of a tumor. The EndOptica oral scan proved feasibility in a 280 patient pilot clinical trial in Bangalore, India.

Through scientific exploration and a unique approach to medical and even environmental application, these medtech teams address a variety of problems and deficits in the healthcare community through the Wayfinder program.

Find out more about the Wayfinder program.

Newsletter Envelope